Revolutionizing Viral Treatment: PharmaDrugs’ Sairiyo Therapeutics Unveils Strategic Roadmap for PD001, a Game-Changing Reformulation of Cepharanthine
PharmaDrug Inc. Announces Strategic Plans for Advancing PD-001 Clinical Development Toronto, Ontario–(Newsfile Corp. – August 28, 2024) PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) (“PharmaDrug” or the “Company”), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is pleased to announce its…